ca.lindholm
Submits third-party assay reports on material purchased directly. Based in Bursa.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
99.55%
n=8
Suppliers covered
6
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041251 | GHK-Cu | WWB | WWB-2512-B1996 | PeptideMeter | 2026-Q2 | 99.43 | 5.87 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043261 | Tirzepatide | CPC | CPC-2605-P1014 | PeptideMeter | 2026-Q2 | 98.60 | 4.61 | 91.8 | Supplier-supplied | 2 | FAIL |
| AX-2026-042190 | TB-500 | JEEP | JEEP-2510-R9238 | PeptideMeter | 2026-Q1 | 99.89 | 4.52 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2025-020931 | Semaglutide | WXT | WXT-2505-E2684 | Nordanalyt | 2025-Q4 | 97.89 | 2.78 | 98.6 | Supplier-supplied | 0 | PASS |
| AX-2025-020098 | MK-677 (Ibutamoren mesylate) | SWB | SWB-2505-G8354 | Janoshik | 2025-Q3 | 99.68 | 2.77 | 96.3 | Buyer-sourced | 0 | FAIL |
| AX-2025-020946 | BPC-157 | WXT | WXT-2501-J3079 | Nordanalyt | 2025-Q1 | 99.00 | 5.30 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005195 | GHRP-6 | CPC | CPC-2401-N1934 | Janoshik | 2024-Q2 | 99.93 | 5.46 | 99.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-005087 | IGF-1 DES (1-3) | SSA | SSA-2403-F6772 | PeptideMeter | 2024-Q2 | 99.67 | 4.18 | 99.0 | Buyer-sourced | 0 | PASS |